# Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease

> **NCT00028093** · PHASE4 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 50 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Peginterferon alfa-2a with Ribavirin
- **DRUG:** Peginterferon alfa-2a

## Key facts

- **NCT ID:** NCT00028093
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028093, "Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00028093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*